Asibitin Cancer na kasar Sin ya dauki hayar Farfesa CraigC.Melloas babban masanin kimiyya 

Daga ranar 8 zuwa 9 ga watan Yuni, Farfesa Craig Melo, wanda ya samu lambar yabo ta Nobel a fannin ilimin halittar jiki ko likitanci, da Farfesa Jiang Wei daga asibitin ciwon daji na kwalejin kimiyyar likitanci ta kasar Sin sun ziyarci Dongping, da ke Shandong, kuma sun halarci taron musanyar ilmin likitanci na likitanci na Nobel kan harkokin ilmin likitanci, wanda asibitin Taimei Baofa ya shirya don zurfafa musayar ilimi. Wannan tafiya alama ce mai mahimmancin haɗin kai na lambar yabo ta Nobel ta cin nasarar fasahar tsoma baki ta RNA da sabuwar hanyar asibiti ta "maganin jinkirin sakin layi", yana shigar da ƙarfi mai ƙarfi a fagen maganin cutar kansa ta duniya, musamman maganin cutar kansar pancreatic.

A cikin 2016, Farfesa Merleau ya yaba wa Farfesa Yu Baofa, darektan asibitin Taimei Baofa Cancer Hospital, don ƙirƙirar "UMIPIC" a "Taron Likitan Laureate na Nobel na Uku". Bayan shekaru tara, wannan tattaunawar da ta samo asali daga manyan dandamali na ilimi na duniya za ta ci gaba da rubuta sabon babi a Dongping, Shandong. Ziyarar Farfesa Meiluo ba wai kawai tattaunawa ce mai zurfi tsakanin manyan ra'ayoyi na kimiyya na kasa da kasa da kirkire-kirkire a cikin gida a kasar Sin ba, har ma da wata sabuwar gada ta hadin gwiwa a fannin binciken ciwon daji tsakanin Sin da kasashen waje.

A wajen taron musanya, Farfesa Melo ya bayyana sabbin abubuwan da ya gani a fagen tsoma bakin RNA da binciken ciwon daji. Farfesa Jiang Wei daga Asibitin Ciwon daji na Kwalejin Kimiyyar Kiwon Lafiyar Jama'a ta kasar Sin ya bayyana cewa, "Art of Cancer Research: Application of RNAi, Animal Models and Super Resolution Imaging." Wani masanin ilimin kimiyya Yu Baofa ya ba da wani bincike na asibiti kan ciwon kansa da ke haifar da ciwace-ciwacen ciwace-ciwacen daji a wajen taron musanya, tare da raba shekaru 27 na kwarewar likitanci ta hanyar yin amfani da maganin cutar kansa. Kafin a fara taron musanya, Farfesa Merleau da Farfesa Yu Baofa sun cimma yarjejeniyar hadin gwiwa ta fannin binciken cutar kansa, kuma sun yi farin ciki da nadin babban masanin kimiya na likitancin Baofa. Farfesa Yu Baofa ya ba da kyauta ga Farfesa Merleau - zanen mai na Merleau wanda Farfesa Yu Baofa ya sanya wa hannu. Cikakken haɗin fasahar kutse ta RNA mai lambar yabo ta Nobel da fasaha na Farfesa Yu Baofa “laburaren sakin layi” shine babbar albarka ga masu cutar kansa. Wannan musayar za ta zama wani dandali na tattara hikimar duniya da kuma karo na sabbin tartsatsin tartsatsi, kuma ana sa ran tsinkayar ra'ayinsa na kimiyya zai nuna alamun ci gaba ga al'ummar cutar kanjamau na cikin gida.

Tun lokacin da aka kafa shi shekaru 27 da suka gabata, asibitin Taimei Baofa Cancer ya sami sakamako mai mahimmanci a cikin amfani da "UMIPIC" don maganin chemotherapy da rigakafi a cikin ciwace-ciwacen daji, musamman ga ciwon daji na pancreatic. An haɗa shi a cikin "Sharuɗɗan Ayyuka na Asibitoci don Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciki" (Trial) (Bugu na Bakwai). Duk da haka, har yanzu akwai bambance-bambancen mutum a cikin tasirin warkewa a ainihin aikin asibiti, kuma ƙungiyar Yu Baofa ta gano tushen bambance-bambancen. An bai wa Farfesa Merleau lambar yabo ta Nobel don hadin gwiwar gano katsalandan na RNA tare da Andrew Farr a cikin 2006. Wannan binciken ya bayyana ainihin tsarin da RNA mai ɗaci biyu zai iya hana bayyanar kwayar halitta musamman, yana buɗe hanyar juyin juya hali don nazarin aikin kwayoyin halitta da kuma gano tushen tushen cututtuka. Fasahar tsoma baki ta RNA ta zama kayan aiki na ginshiƙi a cikin binciken ilimin halittu na zamani, yana ba da sabbin dabaru don magance cututtuka daban-daban ciki har da kansa. Ana sa ran fasahar tsoma baki ta Farfesa Melo ta RNA za ta magance wannan matsalar daidai kuma ta inganta daidaiton ingancin magani. Haɗin fasaha na ɓangarorin biyu ba kawai babban ci gaba ba ne a cikin maganin ciwon daji na pancreatic a duniya, amma kuma zai haɓaka tasirin warkewar “maganin laburare sannu a hankali” akan duk ciwace-ciwacen ciwace-ciwace.

Daga darajar ilimi a shekarar 2016 zuwa yadda ake aiwatar da fasahar zamani, wannan hadin gwiwa wani misali ne na zurfafa hadin kai tsakanin manyan nasarorin binciken kimiyya na kasa da kasa da aikin likitancin kasar Sin. Kamar yadda Gu Fangzhou, tsohon shugaban Kwalejin Kiwon Lafiyar Jama'a ta Peking Union ya kimanta, Farfesa Yu Baofa ya "fara gudanar da binciken kimiyya na asibitoci masu zaman kansu". Gabatar da fasahar Farfesa Melo ba kawai zai inganta matakin maganin ciwon daji a cikin gida da kewaye ba, har ma zai haifar da sabuwar rayuwa ga masu fama da ciwon daji a duk duniya, da kuma inganta maganin cutar daji na ɗan adam zuwa wani sabon tsayi. Kafin tafiyar, Farfesa Merleau ya kuma bayyana cewa kimiyya ba ta san iyaka ba, kuma yaki da cutar kansa yana bukatar hikimar duniya. "Ina fatan samun hadin gwiwa mai zurfi tare da tawagar Farfesa Yu Baofa don gano ingantattun hanyoyin magance cutar kansa tare.